|
Advisory group
Doug Altman University of Oxford, United Kingdom
Gerd Antes Cochrane Centre, Germany
Maurizio Bonati Mario Negri Institute for Pharmacological Research, Italy
An-Wen Chan University of Toronto, Canada
Mike Clarke Queen's University Belfast, United Kingdom
Simon Denegri INVOLVE, Southampton, United Kingdom
Kay Dickersin Johns Hopkins Bloomberg School of Public Health, United States
Jeffrey Drazen New England Journal of Medicine, United States
Lelia Duley University of Nottingham, United Kingdom
Maria Grazia Franzosi Mario Negri Institute for Pharmacological Research, Italy
Ben Goldacre London School of Hygiene and Tropical Medicine, United Kingdom
Sally Hopewell University of Oxford, United Kingdom
Karmela Krleza-Jeric University of Ottawa, Canada
Carol Lefebvre Information consultant, United Kingdom
Richard Lilford University of Birmingham, United Kingdom
David Moher Ottawa Hospital Research Institute, Canada
Chiara Pandolfini Mario Negri Institute for Pharmacological Research, Italy
Lesley Stewart University of York, United Kingdom
Marc Taylor Formerly Department of Health, United Kingdom
Emma Veitch Public Library of Science, United Kingdom
Elizabeth Wager Publications consultant, United Kingdom
Paul Wicks Patientslikeme, United States
18 January 2013
|